Abstract 5483: The Inflammatory Protein Complement C3 is a Novel Substrate for Factor XIII and Impairs Fibrin Clot Lysis
Angela M. Carter(University of Alabama at Birmingham Hospital), Peter J. Grant, Kristina F. Standeven(University of Leeds), Riyaz Somani(University of Leicester), Kerrie A. Smith(University of Leeds), Victoria R Polkinghorne(University of Leeds), Verena Schroeder(University of Bern)
Cited by 0
Related Papers
Homoarginine Levels Are Regulated by <scp>l</scp> -Arginine:Glycine Amidinotransferase and Affect Stroke Outcome
|Circulation|2013|142
Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease
|Journal of the American Heart Association|2017|136
The Functional −374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients
|Diabetes|2003|135
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties
|Diabetes and Vascular Disease Research|2012|80
Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome
|Journal of Thrombosis and Haemostasis|2007|69